Clinical trials

Condition   Drug Name  
Study Pimecrolimus in atopic dermatitis
Design Randomized; Double-blind; Multicenter
Patients 200
Treatment Regimen Pimecrolimus 1% cream top. b.i.d. x 12 wks; Placebo x 6 wks ---> Pimecrolimus 1% cream top. b.i.d. x 6 wks
Conclusions Pimecrolimus significantly improved the quality of life in patients with atopic dermatitis
Reference(s) A randomized controlled trial comparing pimecrolimus cream 1% and vehicle in patients with head & neck atopic dermatitis who are intolerant of, or dependent on topical corticosteroids: Quality of life outcomes
J Invest Dermatol 2007, 127 (Suppl. 1):Abst 326.
Author and Affiliation Murrell, D.F., Ho, V.C., Glendenning, A., Paul, C.F.